Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - Pure Pharmaceuticals CORP | form10q.htm |
| EX-31.1 - CERTIFICATION - Pure Pharmaceuticals CORP | exhibit31-1.htm |
| EX-31.2 - CERTIFICATION - Pure Pharmaceuticals CORP | exhibit31-2.htm |
| EX-32.2 - CERTIFICATION - Pure Pharmaceuticals CORP | exhibit32-2.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002
The undersigned, Roger Gordon, Principal Executive Officer and Director of Pure Pharmaceuticals Corp. (the “Company”), hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) |
the quarterly report on Form 10-Q of the Company for the period ended December 31, 2009 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | |
| (2) |
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: February 12, 2010
/s/ Roger
Gordon
Roger Gordon
President, Principal Executive Officer and
Director